| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 22, 2004
Revised on February 10, 2005
Accepted on February 14, 2005
From the Department of Pharmacology, College of Physicians and Surgeons of Columbia University, New York, NY. Present address for Colleen E. Clancy is the Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, NY.
* To whom correspondence should be addressed. E-mail: rsk20{at}columbia.edu.
IKs, the slowly activating component of the delayed rectifier current, plays a major role in repolarization of the cardiac action potential (AP). Genetic mutations in the
- (KCNQ1) and
- (KCNE1) subunits of IKs underlie Long QT Syndrome type 1 and 5 (LQT-1 and LQT-5), respectively, and predispose carriers to the development of polymorphic ventricular arrhythmias and sudden cardiac death.
-adrenergic stimulation increases IKs and results in rate dependent AP shortening, a control system that can be disrupted by some mutations linked to LQT-1 and LQT-5. The mechanisms by which IKs regulates action potential duration (APD) during
-adrenergic stimulation at different heart rates are not known, nor are the consequences of mutation induced disruption of this regulation. Here we develop a complementary experimental and theoretical approach to address these questions. We reconstituted IKs in CHO cells (ie, KCNQ1 coexpressed with KCNE1 and the adaptator protein Yotiao) and quantitatively examined the effects of
-adrenergic stimulation on channel kinetics. We then developed theoretical models of IKs in the absence and presence of
-adrenergic stimulation. We simulated the effects of sympathetic stimulation on channel activation (speeding) and deactivation (slowing) kinetics on the whole cell action potential under different pacing conditions. The model suggests these kinetic effects are critically important in rate-dependent control of action potential duration. We also investigate the effects of two LQT-5 mutations that alter kinetics and impair sympathetic stimulation of IKs and show the likely mechanism by which they lead to tachyarrhythmias and indicate a distinct role of IKS kinetics in this electrical dysfunction. The full text of this article is available online at http://circres.ahajournals.org.
This article has been cited by other articles:
![]() |
R. C. Ahrens-Nicklas, C. E. Clancy, and D. J. Christini Re-evaluating the efficacy of {beta}-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling Cardiovasc Res, June 1, 2009; 82(3): 439 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Terrenoire, M. D. Houslay, G. S. Baillie, and R. S. Kass The Cardiac IKs Potassium Channel Macromolecular Complex Includes the Phosphodiesterase PDE4D3 J. Biol. Chem., April 3, 2009; 284(14): 9140 - 9146. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Maltsev and E. G. Lakatta Synergism of coupled subsarcolemmal Ca2+ clocks and sarcolemmal voltage clocks confers robust and flexible pacemaker function in a novel pacemaker cell model Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H594 - H615. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Imredy, J. R. Penniman, S. J. Dech, W. D. Irving, and J. J. Salata Modeling of the adrenergic response of the human IKs current (hKCNQ1/hKCNE1) stably expressed in HEK-293 cells Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1867 - H1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Medei, J. H.M. Nascimento, R. C. Pedrosa, L. Barcellos, M. O. Masuda, S. Sicouri, M. V. Elizari, and A. C. Campos de Carvalho Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration Europace, July 1, 2008; 10(7): 868 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Schwartz, E. Vanoli, L. Crotti, C. Spazzolini, C. Ferrandi, A. Goosen, P. Hedley, M. Heradien, S. Bacchini, A. Turco, et al. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. J. Am. Coll. Cardiol., March 4, 2008; 51(9): 920 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Sampson, C. Terrenoire, D. O. Cervantes, R. A. Kaba, N. S. Peters, and R. S. Kass Adrenergic regulation of a key cardiac potassium channel can contribute to atrial fibrillation: evidence from an IKs transgenic mouse J. Physiol., January 15, 2008; 586(2): 627 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, M. L. Marquardt, D. J. Tester, K. J. Sampson, M. J. Ackerman, and R. S. Kass Mutation of an A-kinase-anchoring protein causes long-QT syndrome PNAS, December 26, 2007; 104(52): 20990 - 20995. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakamura, J. Kurokawa, C.-X. Bai, K. Asada, J. Xu, R. V. Oren, Z. I. Zhu, C. E. Clancy, M. Isobe, and T. Furukawa Progesterone Regulates Cardiac Repolarization Through a Nongenomic Pathway: An In Vitro Patch-Clamp and Computational Modeling Study Circulation, December 18, 2007; 116(25): 2913 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Otway, J. I. Vandenberg, G. Guo, A. Varghese, M. L. Castro, J. Liu, J. Zhao, J. A. Bursill, K. R. Wyse, H. Crotty, et al. Stretch-Sensitive KCNQ1 Mutation: A Link Between Genetic and Environmental Factors in the Pathogenesis of Atrial Fibrillation? J. Am. Coll. Cardiol., February 6, 2007; 49(5): 578 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Tan, A. Bardai, W. Shimizu, A. J. Moss, E. Schulze-Bahr, T. Noda, and A. A. M. Wilde Genotype-Specific Onset of Arrhythmias in Congenital Long-QT Syndrome: Possible Therapy Implications Circulation, November 14, 2006; 114(20): 2096 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-u. Choe, E. Schulze-Bahr, A. Neu, J. Xu, Z. I. Zhu, K. Sauter, R. Bahring, S. Priori, P. Guicheney, G. Monnig, et al. C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3{epsilon} Hum. Mol. Genet., October 1, 2006; 15(19): 2888 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rocchetti, V. Freli, V. Perego, C. Altomare, G. Mostacciuolo, and A. Zaza Rate dependency of {beta}-adrenergic modulation of repolarizing currents in the guinea-pig ventricle J. Physiol., July 1, 2006; 574(1): 183 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Missan, P. Linsdell, and T. F. McDonald Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes J. Physiol., June 1, 2006; 573(2): 469 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Boulet, A. L. Raes, N. Ottschytsch, and D. J. Snyders Functional effects of a KCNQ1 mutation associated with the long QT syndrome Cardiovasc Res, June 1, 2006; 70(3): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jespersen, M. Grunnet, and S.-P. Olesen The KCNQ1 Potassium Channel: From Gene to Physiological Function Physiology, December 1, 2005; 20(6): 408 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Brink, L. Crotti, V. Corfield, A. Goosen, G. Durrheim, P. Hedley, M. Heradien, G. Geldenhuys, E. Vanoli, S. Bacchini, et al. Phenotypic Variability and Unusual Clinical Severity of Congenital Long-QT Syndrome in a Founder Population Circulation, October 25, 2005; 112(17): 2602 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, J. Kurokawa, and R. S. Kass Phosphorylation of the A-kinase-anchoring Protein Yotiao Contributes to Protein Kinase A Regulation of a Heart Potassium Channel J. Biol. Chem., September 9, 2005; 280(36): 31347 - 31352. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |